Literature DB >> 29853594

Should we expect all-cause mortality reductions in large screening studies?

Kevin K Dobbin1, Mark Ebell1.   

Abstract

Mesh：

Year:  2018        PMID： 29853594      PMCID： PMC6002009          DOI： 10.3399/bjgp18X696545

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  10 in total

1.  Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? Yes.

Authors:  James Penston
Journal:  BMJ       Date:  2011-10-13

Review 2.  Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening.

Authors:  Ruth Etzioni; Roman Gulati; Leslie Mallinger; Jeanne Mandelblatt
Journal:  Ann Intern Med       Date:  2013-06-04       Impact factor: 25.391

3.  Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.

Authors:  Diana L Miglioretti; Jane Lange; Jeroen J van den Broek; Christoph I Lee; Nicolien T van Ravesteyn; Dominique Ritley; Karla Kerlikowske; Joshua J Fenton; Joy Melnikow; Harry J de Koning; Rebecca A Hubbard
Journal:  Ann Intern Med       Date:  2016-01-12       Impact factor: 25.391

4.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

5.  Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial.

Authors:  Sue M Moss; Christopher Wale; Robert Smith; Andrew Evans; Howard Cuckle; Stephen W Duffy
Journal:  Lancet Oncol       Date:  2015-07-20       Impact factor: 41.316

6.  All-cause mortality in randomized trials of cancer screening.

Authors:  William C Black; David A Haggstrom; H Gilbert Welch
Journal:  J Natl Cancer Inst       Date:  2002-02-06       Impact factor: 13.506

7.  Overdiagnosis in low-dose computed tomography screening for lung cancer.

Authors:  Edward F Patz; Paul Pinsky; Constantine Gatsonis; Jorean D Sicks; Barnett S Kramer; Martin C Tammemägi; Caroline Chiles; William C Black; Denise R Aberle
Journal:  JAMA Intern Med       Date:  2014-02-01       Impact factor: 21.873

8.  Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Marco Zappa; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Liisa Määttänen; Hans Lilja; Louis J Denis; Franz Recker; Alvaro Paez; Chris H Bangma; Sigrid Carlsson; Donella Puliti; Arnauld Villers; Xavier Rebillard; Matti Hakama; Ulf-Hakan Stenman; Paula Kujala; Kimmo Taari; Gunnar Aus; Andreas Huber; Theo H van der Kwast; Ron H N van Schaik; Harry J de Koning; Sue M Moss; Anssi Auvinen
Journal:  Lancet       Date:  2014-08-06       Impact factor: 79.321

9.  Effect of three decades of screening mammography on breast-cancer incidence.

Authors:  Archie Bleyer; H Gilbert Welch
Journal:  N Engl J Med       Date:  2012-11-22       Impact factor: 91.245

10.  Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

Authors:  Ian J Jacobs; Usha Menon; Andy Ryan; Aleksandra Gentry-Maharaj; Matthew Burnell; Jatinderpal K Kalsi; Nazar N Amso; Sophia Apostolidou; Elizabeth Benjamin; Derek Cruickshank; Danielle N Crump; Susan K Davies; Anne Dawnay; Stephen Dobbs; Gwendolen Fletcher; Jeremy Ford; Keith Godfrey; Richard Gunu; Mariam Habib; Rachel Hallett; Jonathan Herod; Howard Jenkins; Chloe Karpinskyj; Simon Leeson; Sara J Lewis; William R Liston; Alberto Lopes; Tim Mould; John Murdoch; David Oram; Dustin J Rabideau; Karina Reynolds; Ian Scott; Mourad W Seif; Aarti Sharma; Naveena Singh; Julie Taylor; Fiona Warburton; Martin Widschwendter; Karin Williamson; Robert Woolas; Lesley Fallowfield; Alistair J McGuire; Stuart Campbell; Mahesh Parmar; Steven J Skates
Journal:  Lancet       Date:  2015-12-17       Impact factor: 79.321
  10 in total
  2 in total

Review 1.  Cancer-Specific Mortality, All-Cause Mortality, and Overdiagnosis in Lung Cancer Screening Trials: A Meta-Analysis.

Authors:  Mark H Ebell; Michelle Bentivegna; Cassie Hulme
Journal:  Ann Fam Med       Date:  2020-11       Impact factor: 5.166

Review 2.  An update on CT screening for lung cancer: the first major targeted cancer screening programme.

Authors:  David R Baldwin; Matthew E J Callister
Journal:  Br J Radiol       Date:  2020-09-07       Impact factor: 3.039
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.